Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06288503

Hydrolysed Rice Formula Study

A Double-blind, Randomised-controlled Trial Evaluating a Hydrolysed Rice Formula Compared to a Cow's Milk Protein-based Extensively Hydrolysed Formula in Infants With Cow's Milk Allergy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
86 (estimated)
Sponsor
Nutricia UK Ltd · Industry
Sex
All
Age
0 Months – 13 Months
Healthy volunteers
Not accepted

Summary

This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.

Conditions

Interventions

TypeNameDescription
OTHERHydrolysed Rice Protein FormulaInfants randomised onto this arm will be taking the hydrolysed rice protein formula, with a minimum prescription of 30% of their energy requirements.
OTHERCow's Milk Based Extensively Hydrolysed FormulaInfants randomised onto this arm will be taking the control product, with a minimum prescription of 30% of their energy requirements.

Timeline

Start date
2024-02-01
Primary completion
2027-07-01
Completion
2027-07-01
First posted
2024-03-01
Last updated
2026-04-13

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06288503. Inclusion in this directory is not an endorsement.